Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study

AIMS: To investigate whether testosterone therapy (TTh) in men with hypogonadism and type 2 diabetes mellitus (T2DM) improves glycaemic control and insulin sensitivity, and results in remission of T2DM. MATERIAL AND METHODS: A total of 356 men who had total testosterone levels ≤12.1 nmol/L (350 ng/d...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Karim Sultan, Haider, Ahmad, Saad, Farid, Doros, Gheorghe, Hanefeld, Markolf, Dhindsa, Sandeep, Dandona, Paresh, Traish, Abdulmaged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689919/
https://www.ncbi.nlm.nih.gov/pubmed/32558149
http://dx.doi.org/10.1111/dom.14122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689919/
https://www.ncbi.nlm.nih.gov/pubmed/32558149
http://dx.doi.org/10.1111/dom.14122

Ejemplares similares